Obesity as a Predictor of Poor Antibody Response to Hepatitis B Plasma Vaccine

JAMA: The Journal of the American Medical Association

Volumn 254, Issue 22, 1985, Pages 3187-3189

  Weber, David J ^a   Rutala, William A ^a   Samsa, Gregory P ^a   Santimaw, Jane E ^a   Lemon, Stanley M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

AGE; ANTIBODY RESPONSE; BODY WEIGHT; DRUG EFFICACY; DRUG THERAPY; HEIGHT WEIGHT RATIO; HEPATITIS B; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER; LIVER DISEASE; METHODOLOGY; NORMAL HUMAN; OBESITY; PREVENTION; PRIORITY JOURNAL; PROPHYLAXIS; THERAPY; VIRUS INFECTION;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; BUTTOCKS; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HOSPITAL BED CAPACITY, 100 TO 299; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; NORTH CAROLINA; OBESITY; OCCUPATIONAL DISEASES; PERSONNEL, HOSPITAL; RETROSPECTIVE STUDIES; VIRAL HEPATITIS VACCINES;

EID: 84944370149     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1985.03360220053027     Document Type: Article

References (18)

1. Dienstag JL, Werner BG, Polk BF, et al.: Hepatitis B vaccine in health care personnel: Safety, immunogenicity, and indicators of efficacy. Ann Intern Med 1984;101:34-40.
2. Francis DP, Hadler SC, Thompson SE, et al.: The prevention of hepatitis B with vaccine: Report of the Centers for Disease Control multi-center trial among homosexual men. Ann Intern Med 1982;97:362-366.
3. Krugman S, Holley HP Jr, Davidson M, et al.: Immunogenic effect of inactivated hepatitis B vaccine: Comparison of 20 microgram and 40 microgram doses. J Med Virol 1981;8:119-121.
4. Szmuness W, Stevens CE, Harley EJ, et al.: Hepatitis B vaccine: Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980;303:833-841.
5. Szmuness W, Stevens CE, Harley EJ, et al.: Hepatitis B vaccine in medical staff of hemodialysis units: Efficacy and subtype cross-protection. N Engl J Med 1982;307:1481-1486.
6. Stevens CE, Szmuness W, Goodman AI, et al.: Hepatitis B vaccine: Immune responses in haemodialysis patients. Lancet 1980;2:1211-1213.
7. American College of Physicians, Health and Public Policy Committee: Hepatitis B vaccine. Ann Intern Med 1984;100:149-150.
8. Recommendation of the Immunization Practices Advisory Committee: Inactivated hepatitis B vaccine. MMWR 1982;31:317-322, 327-328.
9. Suboptimal response to hepatitis B vaccine given by injection into the buttock. MMWR 1985;34:105-108, 113.
10. Schaaff DM, Lender M, Snedeker P, et al.: Hepatitis B vaccine in a hospital. Ann Intern Med 1984;101:720-721.
11. Stevens CE, Alter HJ, Taylor PE, et al.: Hepatitis B vaccine in patients receiving hemodialysis: Immunogenicity and efficacy. N Engl J Med 1984;311:496-500.
12. Vandervelde EM, Mortimer PP: New hepatitis vaccines. Br Med J 1985;290:787.
13. Pead PJ, Saeed AA, Hewitt WG, et al.: Low immune responses to hepatitis B vaccination among healthy subjects. Lancet 1985;1:1152.
14. Kleinbaum DG, Kupper LL, Morganstern H: Epidemiologic Research. Belmont, Calif, Lifetime Learning Publication, 1982.
15. Obese and Overweight Adults in the United States, publication PHS 83-1680. Hyattsville, Md, National Center for Health Statistics, 1983, series 11, No. 230.
16. Cockshott WP, Thompson GT, Howlett LJ, et al.: Intramuscular or intralipomatous injections? N Engl J Med 1982;101:356-358.
17. Keys A, Fidanza F, Karvonen MJ, et al.: Indices of relative weight and obesity. J Chronic Dis 1972;25:329-343.
18. Womersley J, Durnin JVGA: A comparison of the skinfold method with extent of ‘overweight’ and various weight-height relation-ships in the assessment of obesity. Br J Nutr 1977;38:271-284.